BioSpace News Archive

Johnson & Johnson (NYSE: JNJ), the world’s largest and most broadly-based healthcare company, announced today it will host a Health for Humanity investor webcast at 8:00 a.m. Eastern Time on June 18, 2020.

Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ unmet needs and solve therapeutic problems, today announced that due to the public health and safety concerns related to the COVID-19 pandemic the location of its Annual Meeting of Stockholders has been changed to a virtual-only format, via live audio webcast.

Today, the U.S. Food and Drug Administration publicly posted test performance data from four more antibody, or serology, test kits on open.fda.gov from its independent performance validation study effort with the National Institutes of Health’s (NIH) National Cancer Institute (NCI).

A patient-reported symptom tracking method used for patients with cancer has now been adapted for patients with COVID-19.

In the minimally invasive surgeries, small incisions are made on the body. A laparoscope is inserted through one of the incisions or openings to serve as a guide during the surgery. A laparoscope is a tube like instrument that has a lens and a light for viewing. Also, tiny surgical instruments are inserted through other openings in order to undertake the surgery.

In a new report titled ‘Non-Melanoma Skin Cancer Treatment Market: Global Industry Analysis 2012 – 2016 and Forecast 2017 – 2025,’ Persistence Market Research analyzes the global non-melanoma skin cancer treatment market over an eight year forecast period 2017 – 2025 and throws light on the various factors impacting revenue growth of the market over the said period.

Hospitals, medical research institutes, as well as governments, across the globe are hiking their healthcare IT spending to bring reforms in both, operations and outcomes. Instating databases is turning out to be more of a necessity for healthcare institutions, particularly for the field of radiology.

Company is leveraging its integrin platform technology to improve effectiveness of immunotherapies, including Covid-19 vaccines

The University of Kentucky and ArtemiLife Inc. will collaborate on a clinical study using the extract of a medicinal plant grown in Kentucky to test for anti-cancer activity of Artemisia annua and to determine the recommended dose of Artemisia annua for future clinical trials.

Prevalence of endocrine diseases in the US is on a rise as the country’s urban residents continue to bear the brunt of their sedentary lifestyles. Rising incidence of endometriosis, unexplained infertility and polycystic ovarian syndrome (PCOS) continues to alarm public health authorities across the US.